Literature DB >> 20606071

Optimized Nile Red efflux assay of AcrAB-TolC multidrug efflux system shows competition between substrates.

Jürgen A Bohnert1, Brian Karamian, Hiroshi Nikaido.   

Abstract

AcrAB-TolC is the major constitutively expressed efflux pump system that provides resistance to a variety of antimicrobial agents and dyes in Escherichia coli. However, no systematically optimized real-time dye efflux assay has been published for the measurement of its activity and for detection of possible competition between substrates. Here, we report on the development of such an assay using a lipophilic dye, Nile Red. Energy-depleted cells were loaded with the dye in the presence of low (10 microM or less) concentrations of the proton conductor carbonyl cyanide m-chlorophenylhydrazone (CCCP). The CCCP was then removed, and efflux was triggered by energization with glucose. Various known efflux pump inhibitors and antimicrobials were checked for the ability to slow down Nile Red efflux, presumably through competition. Besides the known inhibitors Phe-Arg-beta-naphthylamide and 1-naphthyl-methylpiperazine, several tetracyclic compounds (doxorubicin, minocycline, chlortetracycline, doxycycline, and tetracycline) and tetraphenylphosphonium chloride were found to interfere with dye efflux. This inhibition could not be explained by the depletion of proton motive force. None of the other tested antimicrobials, including macrolides, fluoroquinolones, and beta-lactams, had any impact on Nile Red efflux, even at concentrations of up to 1 mM.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20606071      PMCID: PMC2934970          DOI: 10.1128/AAC.00620-10

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  33 in total

1.  Inhibitors of efflux pumps in Pseudomonas aeruginosa potentiate the activity of the fluoroquinolone antibacterial levofloxacin.

Authors:  T E Renau; R Léger; E M Flamme; J Sangalang; M W She; R Yen; C L Gannon; D Griffith; S Chamberland; O Lomovskaya; S J Hecker; V J Lee; T Ohta; K Nakayama
Journal:  J Med Chem       Date:  1999-12-02       Impact factor: 7.446

2.  Antibiotic susceptibility profiles of Escherichia coli strains lacking multidrug efflux pump genes.

Authors:  M C Sulavik; C Houseweart; C Cramer; N Jiwani; N Murgolo; J Greene; B DiDomenico; K J Shaw; G H Miller; R Hare; G Shimer
Journal:  Antimicrob Agents Chemother       Date:  2001-04       Impact factor: 5.191

3.  Crystal structure of the bacterial membrane protein TolC central to multidrug efflux and protein export.

Authors:  V Koronakis; A Sharff; E Koronakis; B Luisi; C Hughes
Journal:  Nature       Date:  2000-06-22       Impact factor: 49.962

4.  The assembled structure of a complete tripartite bacterial multidrug efflux pump.

Authors:  Martyn F Symmons; Evert Bokma; Eva Koronakis; Colin Hughes; Vassilis Koronakis
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-02       Impact factor: 11.205

5.  Kinetic behavior of the major multidrug efflux pump AcrB of Escherichia coli.

Authors:  Keiji Nagano; Hiroshi Nikaido
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-23       Impact factor: 11.205

6.  Kinetic parameters of efflux of penicillins by the multidrug efflux transporter AcrAB-TolC of Escherichia coli.

Authors:  Siew Ping Lim; Hiroshi Nikaido
Journal:  Antimicrob Agents Chemother       Date:  2010-02-16       Impact factor: 5.191

7.  Mechanism of recognition of compounds of diverse structures by the multidrug efflux pump AcrB of Escherichia coli.

Authors:  Yumiko Takatsuka; Cheng Chen; Hiroshi Nikaido
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-08       Impact factor: 11.205

8.  Non-target gene mutations in the development of fluoroquinolone resistance in Escherichia coli.

Authors:  W V Kern; M Oethinger; A S Jellen-Ritter; S B Levy
Journal:  Antimicrob Agents Chemother       Date:  2000-04       Impact factor: 5.191

9.  Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: novel agents for combination therapy.

Authors:  O Lomovskaya; M S Warren; A Lee; J Galazzo; R Fronko; M Lee; J Blais; D Cho; S Chamberland; T Renau; R Leger; S Hecker; W Watkins; K Hoshino; H Ishida; V J Lee
Journal:  Antimicrob Agents Chemother       Date:  2001-01       Impact factor: 5.191

10.  Identification of Nile red as a fluorescent substrate of the Candida albicans ATP-binding cassette transporters Cdr1p and Cdr2p and the major facilitator superfamily transporter Mdr1p.

Authors:  Irena Ivnitski-Steele; Ann R Holmes; Erwin Lamping; Brian C Monk; Richard D Cannon; Larry A Sklar
Journal:  Anal Biochem       Date:  2009-07-03       Impact factor: 3.365

View more
  58 in total

1.  A fluorescent microplate assay quantifies bacterial efflux and demonstrates two distinct compound binding sites in AcrB.

Authors:  Ramkumar Iyer; Annette Ferrari; R Rijnbrand; Alice L Erwin
Journal:  Antimicrob Agents Chemother       Date:  2015-02-02       Impact factor: 5.191

Review 2.  The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria.

Authors:  Xian-Zhi Li; Patrick Plésiat; Hiroshi Nikaido
Journal:  Clin Microbiol Rev       Date:  2015-04       Impact factor: 26.132

3.  Structure-activity relationships of a novel pyranopyridine series of Gram-negative bacterial efflux pump inhibitors.

Authors:  Son T Nguyen; Steven M Kwasny; Xiaoyuan Ding; Steven C Cardinale; Courtney T McCarthy; Hong-Suk Kim; Hiroshi Nikaido; Norton P Peet; John D Williams; Terry L Bowlin; Timothy J Opperman
Journal:  Bioorg Med Chem       Date:  2015-03-13       Impact factor: 3.641

4.  Molecular mechanism of MBX2319 inhibition of Escherichia coli AcrB multidrug efflux pump and comparison with other inhibitors.

Authors:  Attilio V Vargiu; Paolo Ruggerone; Timothy J Opperman; Son T Nguyen; Hiroshi Nikaido
Journal:  Antimicrob Agents Chemother       Date:  2014-08-11       Impact factor: 5.191

5.  Evidence of a Substrate-Discriminating Entrance Channel in the Lower Porter Domain of the Multidrug Resistance Efflux Pump AcrB.

Authors:  Sabine Schuster; Martina Vavra; Winfried V Kern
Journal:  Antimicrob Agents Chemother       Date:  2016-06-20       Impact factor: 5.191

Review 6.  Synergy and antagonism in natural product extracts: when 1 + 1 does not equal 2.

Authors:  Lindsay K Caesar; Nadja B Cech
Journal:  Nat Prod Rep       Date:  2019-06-19       Impact factor: 13.423

Review 7.  Infection-based chemical screens uncover host-pathogen interactions.

Authors:  Corrella S Detweiler
Journal:  Curr Opin Microbiol       Date:  2020-02-07       Impact factor: 7.934

8.  Importance of Real-Time Assays To Distinguish Multidrug Efflux Pump-Inhibiting and Outer Membrane-Destabilizing Activities in Escherichia coli.

Authors:  Rajeev Misra; Keith D Morrison; Hyun Jae Cho; Thanh Khuu
Journal:  J Bacteriol       Date:  2015-05-11       Impact factor: 3.490

9.  Structure, Assembly, and Function of Tripartite Efflux and Type 1 Secretion Systems in Gram-Negative Bacteria.

Authors:  Ilyas Alav; Jessica Kobylka; Miriam S Kuth; Klaas M Pos; Martin Picard; Jessica M A Blair; Vassiliy N Bavro
Journal:  Chem Rev       Date:  2021-04-28       Impact factor: 60.622

10.  Controlling the Resting Membrane Potential of Cells with Conducting Polymer Microwires.

Authors:  Dhanya T Jayaram; Qingjie Luo; Scott B Thourson; Adam H Finlay; Christine K Payne
Journal:  Small       Date:  2017-05-26       Impact factor: 13.281

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.